These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 32742923)

  • 21. Glucocorticoids are induced while dihydrotestosterone levels are suppressed in 5-alpha reductase inhibitor treated human benign prostate hyperplasia patients.
    Jin R; Forbes C; Miller NL; Strand D; Case T; Cates JM; Kim HH; Wages P; Porter NA; Mantione KM; Burke S; Mohler JL; Matusik RJ
    Prostate; 2022 Oct; 82(14):1378-1388. PubMed ID: 35821619
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cynomorium songaricum Rupr demonstrates phytoestrogenic or phytoandrogenic like activities that attenuates benign prostatic hyperplasia via regulating steroid 5-α-reductase.
    Tao R; Miao L; Yu X; Orgah JO; Barnabas O; Chang Y; Liu E; Fan G; Gao X
    J Ethnopharmacol; 2019 May; 235():65-74. PubMed ID: 30708032
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Age-dependent expression of the androgen receptor gene in the prostate and its implication in glandular differentiation and hyperplasia.
    Prins GS; Jung MH; Vellanoweth RL; Chatterjee B; Roy AK
    Dev Genet; 1996; 18(2):99-106. PubMed ID: 8934871
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Baicalin alleviates benign prostate hyperplasia through androgen-dependent apoptosis.
    Jin BR; An HJ
    Aging (Albany NY); 2020 Feb; 12(3):2142-2155. PubMed ID: 32018227
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Androgens and estrogens in benign prostatic hyperplasia: past, present and future.
    Nicholson TM; Ricke WA
    Differentiation; 2011; 82(4-5):184-99. PubMed ID: 21620560
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stromal androgen receptor roles in the development of normal prostate, benign prostate hyperplasia, and prostate cancer.
    Wen S; Chang HC; Tian J; Shang Z; Niu Y; Chang C
    Am J Pathol; 2015 Feb; 185(2):293-301. PubMed ID: 25432062
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Corni Fructus attenuates testosterone-induced benign prostatic hyperplasia by suppressing 5α-reductase and androgen receptor expression in rats.
    Hwangbo H; Kwon DH; Choi EO; Kim MY; Ahn KI; Ji SY; Kim JS; Kim KI; Park NJ; Kim BH; Kim GY; Hong SH; Park C; Jeong JS; Choi YH
    Nutr Res Pract; 2018 Oct; 12(5):378-386. PubMed ID: 30323905
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting stromal androgen receptor suppresses prolactin-driven benign prostatic hyperplasia (BPH).
    Lai KP; Huang CK; Fang LY; Izumi K; Lo CW; Wood R; Kindblom J; Yeh S; Chang C
    Mol Endocrinol; 2013 Oct; 27(10):1617-31. PubMed ID: 23893956
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Benign prostatic hyperplasia: from bench to clinic.
    Yoo TK; Cho HJ
    Korean J Urol; 2012 Mar; 53(3):139-48. PubMed ID: 22468207
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transcript profiling of the androgen signal in normal prostate, benign prostatic hyperplasia, and prostate cancer.
    Bauman DR; Steckelbroeck S; Peehl DM; Penning TM
    Endocrinology; 2006 Dec; 147(12):5806-16. PubMed ID: 16959841
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of Alginate Oligosaccharide on Testosterone-Induced Benign Prostatic Hyperplasia in Orchiectomized Rats.
    Jang YJ; Jung HY; Myeong JY; Song KH; Kwon J; Kim D; Park JI
    Nutrients; 2023 Jan; 15(3):. PubMed ID: 36771389
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neferine attenuates development of testosterone-induced benign prostatic hyperplasia in mice by regulating androgen and TGF-β/Smad signaling pathways.
    Liu CM; Shao Z; Chen X; Chen H; Su M; Zhang Z; Wu Z; Zhang P; An L; Jiang Y; Ouyang AJ
    Saudi Pharm J; 2023 Jul; 31(7):1219-1228. PubMed ID: 37293563
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The androgen receptor plays different roles in macrophage-induced proliferation in prostate stromal cells between transitional and peripheral zones of benign prostatic hypertrophy.
    Xu D; Wang X; Jiang C; Ruan Y; Xia S; Wang X
    EXCLI J; 2017; 16():939-948. PubMed ID: 28694768
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Etiology and disease process of benign prostatic hyperplasia.
    Isaacs JT; Coffey DS
    Prostate Suppl; 1989; 2():33-50. PubMed ID: 2482772
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mixture of Corni Fructus and Schisandrae Fructus improves testosterone-induced benign prostatic hyperplasia through regulating 5α-reductase 2 and androgen receptor.
    Hwangbo H; Kim MY; Ji SY; Park BS; Kim T; Yoon S; Kim H; Kim SY; Jung H; Kim T; Lee H; Kim GY; Choi YH
    Nutr Res Pract; 2023 Feb; 17(1):32-47. PubMed ID: 36777802
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stromal-AR influences the growth of epithelial cells in the development of benign prostate hyperplasia.
    Chauhan G; Mehta A; Gupta S
    Mol Cell Biochem; 2020 Aug; 471(1-2):129-142. PubMed ID: 32504365
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combination of Ligustri Lucidi Fructus with Ecliptae Herba and their phytoestrogen or phytoandrogen like active pharmaceutical ingredients alleviate oestrogen/testosterone-induced benign prostatic hyperplasia through regulating steroid 5-α-reductase.
    Tao R; Liu E; Zhao X; Han L; Yu B; Mao H; Yang W; Gao X
    Phytomedicine; 2022 Jul; 102():154169. PubMed ID: 35636178
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hormone concentration, metabolic disorders and immunoexpression of androgen and estrogen-alpha receptors in men with benign prostatic hyperplasia and testosterone deficiency syndrome.
    Ryl A; Rotter I; Slojewski M; Dolegowska B; Grabowska M; Baranowska-Bosiacka I; Laszczynska M
    Folia Histochem Cytobiol; 2015; 53(3):227-35. PubMed ID: 26400665
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The extract of Celtis choseniana Nakai alleviates testosterone-induced benign prostatic hyperplasia through inhibiting 5α reductase type 2 and the Akt/NF-κB/AR pathway.
    Hong GL; Kim TW; Lee HJ; Kim YJ; Kim KH; Jung JY
    Chin J Nat Med; 2022 Jul; 20(7):518-526. PubMed ID: 35907650
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.